NS

Naveen Shukla

Active Director Director DIN 07638045
DIN 07638045 First appointment Dec 2016 Primary industry General Business
View timeline Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Past companies 0 historical roles
Total affiliations 1 Since Dec 2016
Shareholding value Locked Premium profile

About Naveen Shukla

Naveen Shukla has 9 years in corporate governance. Holds Director role. Currently with 1 company, including Dunamis Pharmaceuticals Private Limited. Engaged in General Business. Contributes to corporate operations.

DIN 07638045
Primary Designation Director
First Appointment 15 Dec 2016
Oldest Company Age 9 yrs

Current companies

Company Designation Appointment Founded Status
Director 15 Dec 2016 2016 Active

Previous companies

No previous companies available.

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Dunamis Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Naveen Shukla

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Naveen Shukla

Naveen Shukla has 9 years in corporate governance. Holds Director role. Currently with 1 company, including Dunamis Pharmaceuticals Private Limited. Engaged in General Business. Contributes to corporate operations.

Naveen Shukla is associated with 1 company as Director.

Naveen Shukla has expertise in General Business.

Naveen Shukla has 9 years in corporate governance.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available